$5.21
0.449.22%
In chiusura: Aug 21, 5:00 PM EST
$5.27
0.061.15%
Post-mercato: 5:18 PM EST
Arbutus Biopharma Corp
ABUSNASDAQ
PRO
Arbutus Biopharma Earnings & Forecasts
Arbutus Biopharma (ABUS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Arbutus Biopharma Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.03 | $-0.06 | $-0.04 | $-0.04 |
| Actual | $-0.03 | $0.87 | $-0.01 | $-0.04 |
| Surprise | 0.00% | +1550.0% | +75.0% | 0.00% |
| Revenue | ||||
| Estimate | $961000 | $1.5M | $829000 | $1.3M |
| Actual | $1.0M | $179.1M | $1.1M | $529000 |
| Surprise | +5.52% | +11599.9% | +26.8% | -59.6% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.03 | $-0.03 |
| Revenue | ||
| Consensus | $961000 | $1.4M |